Table 3.

Demographics of Participants. The sex, age, ethnicity, days since vaccination, type of vaccine received, and days between visit 1 and visit 2, of 51 participants

	Negative (%)	Asymptomatic (%)	Symptomatic (%)
Sex
Male	4 (44%)	7 (30%)	10 (53%)
Female	5 (66%)	16 (70%)	9 (57%)
Age
Median	22	26	21
Range	19-27	18-40	18-55
Ethnicity
White	9 (100%)	17 (74%)	8 (42%)
Non-white	0 (0%)	4 (17%)	6 (32%)
Unknown	0 (0%)	2 (9%)	5 (26%)
Days since Vaccination
Median	66	75	99.5
Range	17-146	14-192	27-189
Vaccine Type
Pfizer	7 (78%)	12 (52%)	12 (63%)
AstraZeneca	1 (11%)	11 (48%)	3 (16%)
Moderna	1 (11%)	0 (0%)	2 (10.5%)
Unknown	-	-	2 (10.5%)
Days between Visits
Median	206	236	217
Range	106-217	128-282	22-293